Ultraviolet Light Therapy for Systemic Lupus Erythematosus
NCT ID: NCT00004375
Last Updated: 2005-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
20 participants
INTERVENTIONAL
1991-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
I. Evaluate the mechanisms of ultraviolet A-1 light therapy in patients with systemic lupus erythematosus and normal controls.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Treatment with ultraviolet A-1 light is administered 5 days a week for 6 weeks, at the lowest dose or frequency required to maintain a response. The dose and frequency are progressively decreased over the next 9 weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultraviolet A-1 light treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
--Disease Characteristics--
Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American Rheumatism Association criteria and normal controls
--Prior/Concurrent Therapy--
No requirement for tetracycline or other photosensitizing drugs
15 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Louisiana State University Health Sciences Center in New Orleans
OTHER
National Center for Research Resources (NCRR)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hugh McGrath, Jr.
Role: STUDY_CHAIR
Louisiana State University Health Sciences Center in New Orleans
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Clinical Research Center and Charity Hospital (University of Louisiana)
New Orleans, Louisiana, United States
Alton Ochsner Medical Foundation Hospital
New Orleans, Louisiana, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jawed Alam
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
McGrath H, Martinez-Osuna P, Lee FA. Ultraviolet-A1 (340-400 nm) irradiation therapy in systemic lupus erythematosus. Lupus. 1996 Aug;5(4):269-74. doi: 10.1177/096120339600500405.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LSUMC-1765
Identifier Type: -
Identifier Source: secondary_id
LSUMC-910067
Identifier Type: -
Identifier Source: secondary_id
NCRR-M01RR05096-0002
Identifier Type: -
Identifier Source: org_study_id